Express Scripts members who used Propeller's inhaler tracking tools had a significant improvement in adherence to their asthma controller medication, according to the pharmacy benefit manager.
"We’re eager to be better partners to our colleagues at digital health startups and large vendors alike," said Dr. Adam Landman, Brigham and Women’s Hospital CIO.
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
Health X Ventures, a new investor, led the funding round for Madison, Wisconsin-based ImageMoverMD joining several other backers.
Redox will work with Intermountain in the Salt Lake City-based health system's push to adopt digital health solutions that fit into their electronic health record.
Seed and early stage investor RRE Ventures led the round but existing investors took part as well.
The deal adds spirometers and spirometry data to Propeller's platform, expanding the size of the patient population the company targets.
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
Propeller and GlaxoSmithKline announced a joint development agreement less than a year ago.
New investors included strategic investors SR One, the investment arm of GlaxoSmithKline, Hikma Ventures, part of Hikma Pharmaceuticals, and 3M Ventures.
Moxe Health, which is hoping to provide clinical insight to payers and claims information, among other data points, to providers, has raised money in a Series A funding round.
HealthX Ventures was founded by Mark Bakken, who previously founded Nordic Systems, which works with hospitals and healthcare organizations more than 40 states.
As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.
Epic will add native telemedicine support to its EHR and offer free site licenses and support to federally qualified health centers.
In the next few years new products that combine drugs with digital experiences will begin to appear and will likely be more effective than regular drugs, says Chris Hogg of Propeller Health, a speaker at the upcoming MedCity ENGAGE conference in San Diego.
As the year began, healthfinch announced that it had closed a $7.5 million Series A round of venture capital, led by Adams Street Partners.
Wisconsin company's president sees the new Redpoint platform as a "Sherpa" for digital health companies to work with big EHRs.
Propeller Health added another big pharma partner with its GlaxoSmithKline research and development deal to produce sensors for the company's Ellipta dry powder inhaler to monitor COPD and asthma patients.